Group One Trading
OMED

Group One Trading’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Group One Trading’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,600
Closed -$134K – 5510
2017
Q1 		$134K Buy
14,600
+8,300
+132% +$72.9K ﹤0.01% 2794
2016
Q4 		$49K Sell
6,300
-4,700
-43% -$43.2K ﹤0.01% 3280
2016
Q3 		$126K Buy
11,000
+4,600
+72% +$53.5K ﹤0.01% 2795
2016
Q2 		$79K Buy
+6,400
New +$77.7K ﹤0.01% 3029
2015
Q4 		– Sell
-61,500
Closed -$1.02M – 5628
2015
Q3 		$1.02M Buy
61,500
+50,100
+439% +$1M 0.01% 1223
2015
Q2 		$257K Buy
11,400
+4,900
+75% +$121K ﹤0.01% 2351
2015
Q1 		$168K Buy
6,500
+2,900
+81% +$73.6K ﹤0.01% 2523
2014
Q4 		$78K Hold
3,600
– – ﹤0.01% 3050
2014
Q3 		$68K Buy
+3,600
New +$72.3K ﹤0.01% 3322

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Group One Trading's OMED Position: Q3 2018 in Review

Group One Trading sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q3 2018, closing a stake of 8,500 shares — an estimated $20K sold.

Group One Trading first reported a position in OMED in Q3 2015 and held it in 6 quarters. The position peaked at $452K in Q3 2015. 54 funds tracked by Wall St. Rank hold OMED as of Q3 2018.

  • Group One Trading reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Group One Trading sold 8,500 OncoMed Pharmaceuticals, Inc. shares in Q3 2018, an estimated $20K.
  • Group One Trading first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2015 and held it in 6 quarters.
  • Group One Trading's OncoMed Pharmaceuticals, Inc. position peaked at $452K in Q3 2015.
  • 54 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2018.

Based on Group One Trading's 13F filing for Q3 2018, filed 8 Nov 2018.